Navigation Links
New Criteria for Alzheimer's Diagnosis Proposed
Date:7/14/2010

By Steven Reinberg
HealthDay Reporter

WEDNESDAY, July 14 (HealthDay News) -- A draft proposal that would update the diagnostic criteria for Alzheimer's disease for the first time in 25 years has just been presented to Alzheimer's experts.

The key change would put more focus on the various stages of the condition, according to the drafts from three workgroups convened by the U.S. National Institute on Aging and the Alzheimer's Association.

While these criteria are still in use, experts say the field has changed a great deal since they were created in 1984.

"These changes are inevitable, given the forward movement of the scientific knowledge regarding Alzheimer's -- how it develops, how it progresses and how it impacts the patient," said Dr. Martin Goldstein, director of the department of neurology at Mount Sinai School of Medicine in New York City.

Developing methods to identify Alzheimer's in its first stages is essential to the early diagnosis of the disease, he added. This can also lead to new treatments.

"The proposals would change the 1984 criteria by better reflecting the various stages of the disease and the inclusion of Alzheimer's disease biomarkers," William Thies, chief medical and scientific officer at the Alzheimer's Association, said in a news release from the organization.

"While the role of biomarkers differs in each of the three stages, much remains to be understood concerning their reliability and validity in diagnosis. This makes it critical that we thoroughly test any new recommendations," Thies added.

The proposed changes were presented Tuesday at the Alzheimer's Association International Conference on Alzheimer's Disease 2010, in Honolulu.

Among the reasons the criteria need to be updated is the new understanding that Alzheimer's starts years before symptoms are apparent, experts said. The earlier the disease can be identified, the better are the chances to slow its development, they added.

Among the ways researchers are identifying Alzheimer's are through genetic analysis and with biomarkers that can be seen on PET and MRI scans and in cerebrospinal fluid.

These include finding disorders in beta amyloid metabolism and the molecules tau and phospho-tau in cerebrospinal fluid.

In addition, since 1984 there has been a better understanding of the differences between Alzheimer's disease and other types of dementia.

Much more is known about dementia caused by Lewy Body disease and Pick's disease and other frontotemporal dementias.

The proposed changes in diagnosing Alzheimer's will take into account preclinical disease, which can help identify Alzheimer's before symptoms appear; mild cognitive impairment, which can be the first signs of Alzheimer's; and looking into recommending specific biomarkers, which can aid in diagnosis.

Goldstein noted that these proposed changes will lead to new problems, including who should be screened and at what cost. "These changes have significant economic service delivery implications. It has significant public health implications, but it's ultimately a worthy goal," he said.

In addition, there are no effective treatments for Alzheimer's. "Current treatments are primarily symptomatic," Goldstein said. "The ultimate goal is stopping the pathological process long before it develops a momentum that can't be stopped."

Another expert, Mony de Leon, director of the Center for Brain Health at NYU Langone Medical Center in New York City, called the proposed changes "long overdue."

The ultimate goal is to find a treatment for Alzheimer's, de Leon said. "But unless you know who needs the drug, how do you develop a drug?" he stated. "You need the early diagnosis before you can even consider the prevention work."

David Loewenstein, a professor of psychiatry and behavioral sciences at the University of Miami Miller School of Medicine, added that "a diagnosis of Alzheimer's used to be a diagnosis of exclusion."

If a patient had cognitive impairment that interfered with their social functioning, then Alzheimer's disease was the diagnosis by excluding all other causes, he explained.

"These new criteria are based on the fact that new science is showing that we actually have biomarkers that are sensitive to early Alzheimer's disease," Loewenstein said.

More information

For more information on Alzheimer's disease, visit the Alzheimer's Association.

SOURCES: Mony de Leon, Ed.D., professor, department of psychiatry, and director, Center for Brain Health, NYU Langone Medical Center, New York City; Martin Goldstein, M.D., assistant professor, and director, department of neurology, Mount Sinai School of Medicine, New York City; David Loewenstein, Ph.D., professor of psychiatry and behavioral sciences, University of Miami Miller School of Medicine; July 13, 2010, Alzheimer's Association meeting, Honolulu


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Professionals think that there arent criteria for certifying that an illness is terminal
2. New criteria proposed for diagnosing fibromyalgia
3. New CASA* Report Finds: 65 Percent of All U.S. Inmates Meet Medical Criteria for Substance Abuse Addiction, Only 11 Percent Receive Any Treatment
4. Genetic Ancestry Data Improve Diagnosis in Asthma and Lung Disease
5. Many Docs Deliver Cancer Diagnosis Badly: Study
6. Why are blacks more likely to die from cancer diagnosis?
7. AAO-HNS releases consensus statement: diagnosis and management of nasal valve compromise
8. How likely is misdiagnosis?
9. Partners grieve rheumatoid arthritis diagnosis as much as patients
10. Lung cancer research concludes that early diagnosis as key for improving survival
11. False positives in TB diagnosis lead to real negatives for HIV patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Criteria for Alzheimer's Diagnosis Proposed
(Date:1/24/2017)... ... January 24, 2017 , ... ... software products, today announced a strategic partnership with Lucidworks , the company ... and analyze their Fusion platform for building powerful enterprise search applications. , Element ...
(Date:1/24/2017)... ... 2017 , ... The Cruise Web Inc. was recognized today as ... Annual MSC True Partnerships’ Awards. , The 2016 MSC True Partnerships Awards ... based on overall business growth in revenue and guests and continuous partnership support and ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... that its annual Solutions Series of webinars will start January 31 with a ... a number of current health and benefits topics, including employee engagement, pricing transparency, ...
(Date:1/24/2017)... Rancho Santa Margarita, CA (PRWEB) , ... January 24, 2017 , ... ... career advancement platform for 21st century leadership, has named Hector M. Chavez, Manager, Employee ... cancer and diabetes treatment center - as its Hispanic Leader of the Month. City ...
(Date:1/24/2017)... Boston, MA (PRWEB) , ... January 24, 2017 ... ... What They Really Need to Thrive , Well-meaning studies such as the Fordham ... and schools can better serve top students, such as including gifted or high-achieving ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... and PUNE, India , January ... published by Allied Market Research, titled, "Cold Chain Logistics ... Confectionary, Dairy & Frozen Dessert, Meat, Fish & Sea ... Analysis and Industry Forecasts, 2014-2022," projects that the global ... million by 2022, growing at a CAGR of 16% ...
(Date:1/24/2017)... , Jan. 24, 2017 Regeneron Pharmaceuticals, ... the Public today recognized 40 finalists in the Regeneron ... science and math competition for high school seniors. Finalists ... potential of their research projects. The finalists ... from March 9-15 to undergo a rigorous judging ...
(Date:1/24/2017)... -- Research and Markets has announced the addition of ... Material - Forecast to 2025" report to their offering. ... The Global Implantable ... around 5.4% over the next decade to reach approximately $54.28 billion ... market is witnessing include 3D medical printing is expected to develop ...
Breaking Medicine Technology: